» Articles » PMID: 25943721

Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2015 May 7
PMID 25943721
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Limited information exists on the predonation costs incurred by eventual living kidney donors (LKDs). Expenses related to completion of the donation evaluation were collected from 194 LKDs participating in the multi-center, prospective Kidney Donor Outcomes Cohort (KDOC) Study. Most LKDs (n = 187, 96%) reported one or more direct costs, including ground transportation (80%), healthcare (24%), lodging (17%) and air transportation (14%), totaling $101 484 (USD; mean = $523 ± 942). Excluding paid vacation or sick leave, donor and companion lost wages totaled $35 918 (mean = $187 ± 556) and $14 378 (mean = $76 ± 311), respectively. One-third of LKDs used paid vacation or sick leave to avoid incurring lost wages. Few LKDs reported receiving financial support from the transplant candidate (6%), transplant candidate's family (3%), a nonprofit organization (3%), the National Living Donor Assistance Center (7%), or transplant center (3%). Higher total costs were significantly associated with longer distance traveled to the transplant center (p < 0.001); however, total costs were not associated with age, sex, race/ethnicity, household income, marital status, insurance status, or transplant center. Moderate predonation direct and indirect costs are common for adults who complete the donation evaluation. Potential LKDs should be advised of these possible costs, and the transplant community should examine additional strategies to reimburse donors for them.

Citing Articles

Living Donor Candidates' Self-reported Health and Health Perceptions and Completion of Donor Evaluation: A Cohort Study.

Ku E, Legaspi S, Copeland T, Adey D, Whelan A, Roll G Kidney Med. 2024; 6(11):100909.

PMID: 39534796 PMC: 11554918. DOI: 10.1016/j.xkme.2024.100909.


Donor Perceptions and Preferences of Telemedicine and In-Person Visits for Living Kidney Donor Evaluation.

Kim E, Sung H, Kaplow K, Bendersky V, Sidoti C, Muzaale A Kidney Int Rep. 2024; 9(8):2453-2461.

PMID: 39156145 PMC: 11328557. DOI: 10.1016/j.ekir.2024.05.009.


Financial toxicity in living donor liver transplantation: A call to action for financial neutrality.

Kaplan A, Aby E, Scott S, Sonnenday C, Fox A, Mathur A Am J Transplant. 2024; 24(10):1742-1754.

PMID: 38763318 PMC: 11439575. DOI: 10.1016/j.ajt.2024.05.012.


Telemedicine services for living kidney donation: A US survey of multidisciplinary providers.

Al Ammary F, Motter J, Sung H, Lentine K, Sharfuddin A, Kumar V Am J Transplant. 2022; 22(8):2041-2051.

PMID: 35575439 PMC: 9543040. DOI: 10.1111/ajt.17093.


The Advancing American Kidney Health (AAKH) Executive Order: Promise and Caveats for Expanding Access to Kidney Transplantation.

Lentine K, Mannon R Kidney360. 2020; 1(6):557-560.

PMID: 32587954 PMC: 7316167. DOI: 10.34067/KID.0001172020.


References
1.
Klarenbach S, Garg A, Vlaicu S . Living organ donors face financial barriers: a national reimbursement policy is needed. CMAJ. 2006; 174(6):797-8. PMC: 1402383. DOI: 10.1503/cmaj.051168. View

2.
Clarke K, Klarenbach S, Vlaicu S, Yang R, Garg A . The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant. 2006; 21(7):1952-60. DOI: 10.1093/ndt/gfl069. View

3.
Schulz-Baldes A, Delmonico F . Improving institutional fairness to live kidney donors: donor needs must be addressed by safeguarding donation risks and compensating donation costs. Transpl Int. 2007; 20(11):940-6. DOI: 10.1111/j.1432-2277.2007.00542.x. View

4.
Rodrigue J, Cornell D, Kaplan B, Howard R . Patients' willingness to talk to others about living kidney donation. Prog Transplant. 2008; 18(1):25-31. DOI: 10.1177/152692480801800107. View

5.
Sickand M, Cuerden M, Klarenbach S, Ojo A, Parikh C, Boudville N . Reimbursing live organ donors for incurred non-medical expenses: a global perspective on policies and programs. Am J Transplant. 2009; 9(12):2825-36. PMC: 4388151. DOI: 10.1111/j.1600-6143.2009.02829.x. View